ரேமஂட் பில News Today : Breaking News, Live Updates & Top Stories | Vimarsana

December 16, 2020 08:19 As U.S. hospitals ramped up COVID-19 vaccinations Tuesday with the first vaccine approved for emergency use, federal regulators issued a favorable review of a second vaccine needed to combat the country s worsening crisis. The Food and Drug Administration said its preliminary analysis of a vaccine developed by Moderna and the National Institutes of Health confirmed its safety and effectiveness. The FDA s review moves the Moderna vaccine closer to regulatory authorization and comes as U.S. hospitals increased vaccinations with the shot developed by Pfizer and BioNTech, which the FDA cleared for emergency use last week. A committee of outside expert advisers will offer their recommendation on the Moderna vaccine on Thursday, with a final FDA decision expected shortly thereafter. FDA staff members did not raise any significant new concerns about the Moderna vaccine in documents, released Tuesday, that were prepared for Thursday s meeting of experts.

United statesGeorge washington university hospitalDistrict of columbiaMoncef slaouiSteven hahnGustave pernaJohns hopkins universityArmy genDrug administrationRaymond plaOperation warp speedJohns hopkinsDrug administration commissioner steven hahnஒன்றுபட்டது மாநிலங்களில்ஜார்ஜ் வாஷிங்டன் பல்கலைக்கழகம் மருத்துவமனைமாவட்டம் ஆஃப் கொலம்பியா